论文部分内容阅读
目的探究多囊卵巢综合征患者通过炔雌醇环丙孕酮片(达英35)治疗后取得的临床疗效。方法 60例多囊卵巢综合征患者,按照随机分组标准分为观察组和对照组,每组30例。对照组采用二甲双胍治疗,观察组采用达英35进行治疗。观察两组临床疗效、性激素水平改善情况。结果对照组治疗总有效率(70.0%)明显低于观察组(93.3%),差异有统计学意义(P<0.05)。治疗前两组患者性激素水平对比差异无统计学意义(P>0.05);治疗后,观察组性激素水平改善情况优于对照组(P<0.05)。结论多囊卵巢综合征患者通过达英35治疗后,在提高治疗效果的同时,使患者性激素水平显著改善,具有一定推广价值。
Objective To investigate the clinical efficacy of polycystic ovary syndrome patients treated with ethinyl estradiol cyproterone tablets (up to Ying 35). Methods Sixty patients with PCOS were divided into observation group and control group randomly according to the criteria of 30 cases. The control group was treated with metformin, and the observation group was treated with Dayang 35. The clinical efficacy and the level of sex hormones in both groups were observed. Results The total effective rate (70.0%) in the control group was significantly lower than that in the observation group (93.3%), the difference was statistically significant (P <0.05). There was no significant difference in sex hormones between the two groups before treatment (P> 0.05). After treatment, the improvement of sex hormones in the observation group was better than that in the control group (P <0.05). Conclusion Polycystic ovary syndrome patients treated with up to 35, while improving the therapeutic effect, while patients with sex hormone levels significantly improved, with some promotional value.